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Long occlusionAbstract Sub-intimal angioplasty (SIA) is a recognized endovascular option for long segment
occlusive disease. The Inter-Society Consensus for the Management of peripheral arterial disease
(TASC) published a revised classiﬁcation for infra-inguinal peripheral vascular disease in 2007.
We present our experience with this technique and aim to determine the efﬁcacy of sub-intimal
angioplasty (SIA) for TASC C and TASC D category lesions.
Materials and Methods: A retrospective analysis of all consecutive SIA for TASC C and D super-
ﬁcial femoral artery (SFA) occlusions was conducted. The procedures were carried out in a single
center between 01/11/2009 and 01/06/2011. Primary endpoints were limb salvage rates. Secondary
endpoints were primary, primary assisted, secondary patency, and complication rates. Kaplan–
Meier analysis was used to assess the patency, limb salvage and survival rates.
Results: 29 limbs in 26 patients were treated, median age 69 years. Indications included moderate
to severe claudication in 18 limbs and critical limb ischemia (CLI) in 11 limbs. There were six TASC
C and 23 TASC D lesions with a median lesion length of lesion 27.3 cm (15.2–46.4). Complications
occurred in 3 cases (10%), which were all distal embolization. All 3 had successful thrombo-
aspirations and were treated with IV heparin for 24–48 h. The technical and clinical success rates
were 93.1%. The primary patency rate, primary assisted patency and secondary patency at 1 year
of approximately were 41%, 57% and 60% respectively. There was one below knee amputation
in the study group, giving a cumulative proportional limb salvage rate of 96.6%. The primary
patency of the CLI group was 60% at 1 year.
Conclusion: Although we observed a low primary patency rate there were encouraging limb salvage
rates in patients with TASC C and D lesions treated with SIA. It provides an alternative to surgery
in high risk patients, with acceptable technical success and complication rates but re-intervention is
likely to be required.
 2015 The Authors. The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting
by Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).47818.
Table 2
Weighting of runoﬀ arteries
Site of
intervention
No. of units assigneda
3 2 1
CIA EIA ILA
EIA CFA or SFA PROF
CFA SFA PROF
SFA, POP AT, PT, PER
AT Distal tibial Pedal Arch
PT Distal tibial Pedal Arch
PER Pedal Arch Collaterals to
AT and PT
DP Pedal Arch
CIA = common iliac artery, EIA = external iliac artery,
IIA = internal iliac artery, CFA= common femoral artery,
SFA= superﬁcial femoral artery, POP = popliteal
artery, PROF= profunda femoris artery, AT = anterior tibialis
artery, PT = posterior tibialis artery, PER= peroneal artery,
DP = dorsalis pedis artery.
a Points assigned for degree of occlusion: 3 = occluded
throughout most of its length; 2 = 50–99% stenosed; 1 = 20–49%
stenosed; 0 = normal or less than 20 < stenosed.
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In 1989, Bolia described the use of subintimal angioplasty
(SIA) as an alternative method of lower limb revascularization.
Since its description, this technique has become increasingly
popular and has a role in the management of peripheral vascu-
lar disease. Conventionally, complete total occlusions (CTO)
of >10 cm were treated with a surgical bypass. Over the past
2 decades, we have witnessed a change in practice which may
be attributable to many factors including the expansion of
interventional radiology services and improvement of catheters
and balloons. As the scope of SIA as a treatment option for
peripheral arterial disease (PAD) widens, the patient selection
has also dramatically changed. SIA has been originally
described in managing superﬁcial femoral artery (SFA) and
popliteal artery (PA) occlusions, and is now applied in iliac
and crural arteries. There are numerous published outcome
studies since the description of the technique but there is scarce
data on long CTO i.e. Trans-atlantic Inter-Society Consensus
(TASC II) C and TASC D lesions.
The purpose of this study is to perform a subset analysis of
CTOs more than 15 cm treated with SIA in our center.
2. Material and methods
This is a single center retrospective subset analysis of
subintimal angioplasty (SIA) performed in our unit. In our
institution, all elective vascular cases are discussed in the
multi-disciplinary meeting (MDT). Patients are discussed
before and after treatment and information is recorded in
the vascular database.
All patients who underwent SIA from November 2009 to
June 2011 were prospectively recorded in a SIA database.
Further procedural information was obtained from the depart-
mental radiology information system. All the patients who had
SIA were identiﬁed and recruited into this study according to
the inclusion and exclusion criteria (Table 1).
Before SIA, all patients had imaging to ensure there was a
sufﬁcient inﬂow into the infrainguinal circulation. The ﬁrst line
investigation was Doppler ultrasound but some patients had
CT angiography or MR angiography. All patients were started
on an antiplatelet agent and statin when reviewed in clinic or
on admission. Full clinical history, physical examination and
ankle brachial pressure index (ABPI) were recorded (see
Table 2).
Patients with estimated glomerular ﬁltration rate (eGFR) of
less than 30 received pre- andpost-procedural intravenous hydra-
tion. Diabetic patients on Metformin were converted to anotherTable 1 Inclusion and exclusion criteria.
Inclusion criteria
Clinical status: fontaine > 2a (not inclusive)
DSA documentation of CTO of SFA± PA
Subintimal transition of occluded lesion > 15 cm
Discussed in vascular multi-disciplinary meeting and deems SIA
as the best management for patient
Exclusion criteria
Fontaine 1–2a
History of contrast hypersensitivity
Acute limb ischemiaantiglycaemic agent 24 h before and 48 h after the procedure.
Following the procedure, patients with intermittent claudication
whowere scheduled as a day-caseweremonitored for 6 h and dis-
charged if there were no immediate complications. The majority
of patients who had critical limb ischemia (CLI) were inpatients
and thus, monitored on a vascular surgical ward.
Following SIA, patients were started on dual anti-platelets,
with aspirin and clopidogrel 75 mg once daily each for
6 weeks, if there were no contraindications.
2.1. Procedure
SIA was performed as described by Amman Bolia. The ipsilat-
eral antegrade approach is preferable as it provides better wire
control and pushability. Contralateral retrograde approach is
reserved for cases where an antegrade approach was not pos-
sible. The majority of procedures are performed via a 5Fr
sheath. 4000 IU of heparin is administered during the proce-
dure followed by 1000 IU every subsequent hour.
The subintimal channel is achieved by creating a ‘Bolia loop’
either with a 0.035’’ Radiofocus or with a half stiff J tip hydro-
philic wire (Terumo, Tokyo, Japan). The wire was initially sup-
ported by a 4 Fr short angled Bolia catheter (Terumo, Tokyo,
Japan) followed by a 4 or 5 mm balloon catheter. Once re-entry
has been achieved and conﬁrmed, the subintimal channel is
immediately dilated with an appropriate balloon. Stenting
is only deployed in cases where satisfactory hemodynamics is
not achieved on angiography. This is usually due to elastic
recoil or signiﬁcant stenosis of >30%. When stenting is
required, the entire subintimal channel including entry and
re-entry points is stented with a self-expanding stent Fig. 1.
2.2. Follow-up
Following SIA, all patients were routinely scheduled for a
Doppler ultrasound and reviewed in an outpatient clinic at
Fig. 1 (a and b) Digital subtraction angiography (DSA) showing a short stump of the right SFA, the rest of the SFA and the popliteal
artery are occluded, with patent anterior tibial artery as a single run-off vessel. (c–e) Post SIA, recanalization of the SFA and popliteal
artery. This patient had patent arteries on a Doppler examination 3 years later.
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Table 4 Baseline patient demographics.
Age (years)
Median 69
Range 51–88
Gender (number of patients)
Male 20
Female 6
Risk factors (number of patients)
CKD3–5 (eGFR< 60) 5
970 H. Abdelsalam et al.6 weeks, 6 months and a year. They have an option to make an
appointment in between scheduled appointments whenever
symptoms recur. In clinic, pre- and post-procedural ABPI
and clinical symptoms were recorded.
If patients failed to attend clinic, we telephoned them to
obtain clinical information.
Patients do not receive further scheduled follow-up if they
remain asymptomatic after a year. The radiology information
system is linked with the death registry enabling us to ﬁnd out
whether the patient is deceased even if they were no longer
followed-up.
2.3. Deﬁnitions and study endpoints
Primary endpoints for this study were limb salvage rate and
primary patency.
Secondary endpoints were technical success, clinical
success, primary assisted patency, secondary patency and com-
plication rates.
Technical success was deﬁned as successful transition of the
target lesion through the sub-intimal space and re-entry into
the true lumen, with satisfactory angiographic appearance with
no signiﬁcant elastic recoil or residual stenosis of >30%.
Clinical success was deﬁned by the improvement of present-
ing symptoms, as judged subjectively by the patient in the case
of intermittent claudication or ischemic rest pain and by the
improvement or full healing of the ulcer in patients with tissue
loss. This was assessed 6 weeks post-procedure and patients
were then followed up for a year to assess if they remained
symptom free.
Lesion length was measured preferably from CT or MR
angiography prior to SIA. In cases where patients only had a
Doppler ultrasound as the initial investigation, we used cali-
brated angiographic images from the procedure.
Limb salvage is deﬁned as survival without any event of
ipsilateral above or below knee amputation.
Primary patency is deﬁned as uninterrupted patency with-
out any additional procedure, either surgical or endovascular,
of the previously treated lesion.
Assisted primary patency is deﬁned as patency from the
time of procedure to the time of occlusion of the previously
treated lesion, regardless of the number of procedures in the
interim.
SVS scores were recorded according to angiographic
appearance as described by Peterkin et al. (1).
Complications are graded to minor and major complica-
tions in line with the Society of Interventional Radiology
categories (Table 3).Table 3 Complications.
Deﬁnitions of complications
Minor complications
A. No therapy, no consequence
B. Nominal therapy, no consequence, includes overnight
admission for observation only
Major Complications
C. Require therapy, minor hospitalization (<48 h)
D. Require major therapy, unplanned increase in level of care,
prolonged hospitalization (>48 h)
E. Permanent adverse sequelae
F. DeathKaplan–Meier analysis was used to assess the patency, limb
salvage and survival rates. In subgroup analyses, log rank test
was used as the default method. However, this is appropriate
when relative mortality/re-stenosis does not change with time.
This is known as ‘‘proportional hazard’’. Immediately after
SIA, the risk of complications is high initially violating the
proportional hazard assumption. For this reason, we applied
the Breslow test (Wilcoxon test) too, which gives more empha-
sis to early deaths/events. Statistical analysis was performed
with SPSS software (version 20.0; SPSS Inc, Chicago, IL,
USA). The threshold of statistical signiﬁcance was set at 5%.
3. Results
42 infra-inguinal SIA procedures were performed in 37
patients during this period. Of these, 29 limbs on 26 patients
fulﬁlled the inclusion criteria for the subset analysis of long
occlusions. This comprised of 20 male and 6 female patients
with a mean age of 69 years. 18 patients presented with inter-
mittent claudication, 2 with rest pain and 9 had ulceration or
gangrene (Table 4).
All treated lesions were infra-inguinal CTO, 23 exclusively
SFA and 6 SFA-popliteal lesions. The mean length of the
lesions was 27.3 cm (15.3–46.4). The mean SVS run-off scores
were 3.6 (0–8) (Table 5).
Initial technical success was achieved in 27/29 of cases. The
reason for both technically unsuccessful cases were due to fail-
ure to break back into the true lumen. No re-entry devices
were used in any of the cases. There were three major Class
C complications in the form of distal thrombo-embolization
which were successfully treated with suction thrombectomy
and commenced on IV heparin. All 3 patients were admitted
overnight, received IV heparin for 24–48 h and reported symp-
tom improvement on follow-up. No minor complications were
reported.Current smoker 15
Diabetes mellitus 7
Hypertension 20
Ischemic heart disease 18
Clinical category (fontaine classiﬁcation)
I (asymptomatic) 0
IIa (mild claudication) 0
IIb (moderate to severe claudication) 18
III (ischemic rest pain) 2
IV (ulceration or gangrene) 9
Concomitant medication (number of patients)
Statins 21
Anti-platelet therapy 18
Warfarin or phenindione 1
Table 5 Lesion characteristics.
Lower limb
Left 14
Right 15
Break back point (number of limbs)
Above joint line – SFA 23
Below joint line SFA/popliteal artery 6
Length of occlusion (centimeter)
Median 27.3
Range 15.3–46.4
SVS run-oﬀ score
Median 3.6
Range 0–8
Reason for stent deployment (number of patients) 8/29
Recoil 7
Fresh thrombus 1
ABPI
Median pre-procedure ABPI 0.59
Median post-procedure ABPI (6 weeks) 0.90
Median ABPI change 0.33
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from malignancies and one due to myocardial infarction more
than 30 days post-procedure.
The mean duration of clinical follow-up was 414 days
(median = 367 days).
Kaplan–Meier analysis showed a three-year cumulative
proportional mortality rate of 82.5%.
With respect to limb salvage rate, there was only one below
knee amputation in the study group giving a three-year cumu-
lative proportional limb salvage rate of 96.6%. Following SIA,
the target vessel thrombosed within 3 months. The patient
went on to have a femoral-popliteal bypass graft which throm-
bosed three times within a year (Table 6).
3.1. Primary patencyCase processing summaryTotal N N of events CensoredN Percent (%)29 17 12 41.4aLife tableInterval start time0 6 12 18 24Number exposed to risk 27.5 18.0 6.5 2.0 1.0aThe median survival time is 10.445.3.2. Primary assisted patencyCase processing summaryTotal N N of events CensoredN Percent (%)29 12 17 58.6aLife tableInterval start time0 6 12 18 24Number exposed to risk 27.5 17.5 8.0 3.0 1.5aThe median survival time is 24.000.
Table 6 Outcomes.
Technical success 93%
Clinical success 93%
Duration of clinical follow-up (months)
Mean 13.8
Median 12.2
Range 2.8–34.5
Symptom recurrence
Median (months) 12.6
Range 0–19.3
Primary patency
Median 8.4
Range 0–34.5
Time to next intervention (months)
Median 8.4
Range 3.4–16.7
Time to occlusion (months)
Median 11.5
Range 0–29.9
Patient survival (months)
Median 31.3
Range 6.7–39.9
Limb salvage rate (months)
Median 31.3
Range 3–39.9
Complications (number of limbs)
Minor 0
Major 3
Closure device 7
9723.3. Secondary patencyCase processing summaryTotal N N of events CensoredN Percent (%)29 11 18 62.1a
H. Abdelsalam et al.Life tableInterval start time0 6 12 18 24Number exposed to risk 27.5 19.5 10.0 4.0 2.0aThe median survival time is 24.000.Case processing summaryTotal N N of events CensoredN Percent (%)29 3 26 89.7
Subintimal angioplasty for long (TASC C and D) superﬁcial femoral artery occlusions 973Case processing summaryTotal N N of events CensoredN Percent (%)29 1 28 96.63.4. ComparisonsOverall comparisonsChi-square df Sig.Log rank (Mantel-Cox) .637 1 .425Breslow (generalized Wilcoxon) .380 1 .538Test of equality of survival distributions for the different levels of
critical ischemia.Case processing summaryCritical ischemia Total N N of events CensoredN Percent (%)No 18 8 10 55.6Yes 11 3 8 72.7Overall 29 11 18 62.1Overall comparisonsChi-square df Sig.Log rank
(Mantel-Cox)1.614 2 .446Tarone-Ware 1.425 2 .490Test of equality of survival distributions for the different levels of
no of calf vessels.Case processing summaryNo of calf
vesselsTotal N N of events CensoredN Percent (%)1 4 2 2 50.02 8 4 4 50.03 17 5 12 70.6Overall 29 11 18 62.1
974 H. Abdelsalam et al.Overall comparisonsChi-square df Sig.Log rank (Mantel-Cox) 2.917 1 .088Breslow (generalized Wilcoxon) 4.033 1 .045Case processing summarySmokers Total N N of events CensoredN Percent (%)0 14 3 11 78.61 15 8 7 46.7Overall 29 11 18 62.14. Discussion
During the study period, our institution performed 42 infra-
inguinal SIA for CTO, of which 29 had disease in the TASC
C and D category. Venous bypass has traditionally been con-
sidered the ﬁrst line treatment for these lesions with reported
5 year patency rate of up to 69%. However, this is reliant on
the availability of good quality veins and outﬂow popliteal
or infra-geniculate arteries. When good veins are not available
for bypass, it is debatable if prosthetic graft bypass is superior
to SIA especially in CLI. As an institution, we have a low
threshold to attempt SIA in patients with severe claudication
or critical ischemia before considering bypass surgery in
patients with multiple co-morbidities as there is an increased
risk of perioperative mortality.
In 2007, Ko et al. compared SIA vs. intraluminal angio-
plasty of long femoro-popliteal occlusions with an average
length of 22.7 ± 9.9 cm. The primary patency of the SIA
group on an intention-to-treat basis was 72.4% at 1 year. In
their study, the entry site of all SIA cases was stented and
patients were on a combination of aspirin and cilostazol ordual antiplatelet therapy for at least one year. Patients with
poor distal run-off were sometimes started on warfarin at the
operator’s discretion. This practice is considerably different
from our center where patients are only on dual antiplatelet
therapy for 6 weeks and none were started on warfarin for
poor run-offs. We have never prescribed cilostazol for our
patients with peripheral vascular disease, but there is increas-
ing evidence that cilostazol may reduce the risk of stenosis
especially in patients with high risk of re-stenosis without
increased risk of bleeding (2).
In 2010, Taneja et al. reported their results of 49 long length
SFA and popliteal artery stenting in diabetic patients with a
mean CTO of 20 cm. The primary patency rate at one year
was low at 27% but the limb salvage rate at 1 year was accept-
able at 80%. There were only 6 patients with diabetes in our
cohort, thus only limited conclusions can be drawn from com-
paring the two studies. However, there is a similar trend of low
primary patency rates and multiple re-interventions are
required in patients with TASC C and D disease, but amputa-
tions are successfully prevented.
Dimitris et al. reported that CTO longer than 20 cm had an
angiographic binary re-stenosis hazard ratio of 4.55 compared
to lesions less than 20 cm. Other factors reported to negatively
affect binary angiographic stenosis include initial CLI symp-
toms and full lesion stenting (3). They found that selective
entry/re-entry stenting was linked to lower re-stenosis rates.
In the subgroup of initial CTO more than 20 cm, the
re-stenosis rate at 1 year was more than 60%.
We have detected a signiﬁcant difference in secondary
patency between smoker and non-smokers (48% vs. 73% at
24 months, p= 0.045). It is expected that smokers will have
poorer patency rates than non-smokers but we did not think
that there will be such a signiﬁcant difference between the
two groups. The Basil Trial showed a hazard ratio of 1.72
for ex-smokers and 1.5 for current smokers in their multi-
variate analysis (4). This hazard ratio was linked to survival
rather than patency rates. There were more patients with crit-
ical limb ischemia and diabetes within the non-smoking group
suggesting that these confounding factors should reﬂect a
poorer patency rate in this group and yet it fared better than
the smoking group. Unfortunately, a more detailed smoking
history was not obtained during initial patient assessment.
We believe that this is required for future studies to determine
which smoking associated factors affected patency rates, e.g.
number of pack years, type of cigarettes, etc.
We recognize there are limitations in our single-center study
with a small study group with heterogeneity of critical and
non-critical limbs. Although our sample size is small, the
evidence in the literature on TASC C and D CTO is currently
limited. We believe that this study may be a valuable addition
to the body of evidence that demonstrates SIA is a safe and
effective alternative for long severe CTO. This remains with
the caveat that a rigorous surveillance program and a
re-intervention policy are in place to ensure reasonable rates
of primary assisted patency.5. Conclusion
In conclusion, SIA is effective alternative in treating TASC C
and D CTOs with limb salvage and survival rates comparable
to surgery. Although the re-intervention rates are high, it
Subintimal angioplasty for long (TASC C and D) superﬁcial femoral artery occlusions 975remains a viable treatment option especially in high risk surgi-
cal candidates with multiple co-morbidities. Smoking
decreases patency rates and more detailed smoking history is
required in future studies to determine which smoking associ-
ated factor is responsible.
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